Coloplast A/S (OTCMKTS:CLPBY) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Coloplast A/S (OTCMKTS:CLPBY) issued its earnings results on Friday. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.09 by $0.01, reports. The business had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.12 billion. Coloplast A/S had a return on equity of 24.99% and a net margin of 13.01%.

Coloplast A/S Stock Performance

Shares of CLPBY opened at $7.81 on Friday. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.61 and a quick ratio of 1.00. Coloplast A/S has a one year low of $7.75 and a one year high of $11.44. The firm has a market capitalization of $17.60 billion, a P/E ratio of 32.54, a PEG ratio of 0.82 and a beta of 0.26. The business has a fifty day moving average of $8.64 and a 200 day moving average of $9.08.

Analysts Set New Price Targets

Separately, Sanford C. Bernstein raised Coloplast A/S to a “hold” rating in a research report on Wednesday, January 28th. Three investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has an average rating of “Hold”.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.